Biogen

225 Binney Street
Cambridge
MA
United States

Tel: 781-464-2000

2020 Ideal Employer
2022 Best Places to Work
Show jobs for this employer

About Biogen

At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, neuropsychiatry, immunology, acute neurology and neuropathic pain.

Company Ownership: Public
Stock Symbol: BIIB
Stock Exchange: NASDAQ

Facebook Twitter YouTube Logo

Courage, resilience, hope. These are the qualities we seek to preserve. They are also the qualities that drive us to preserve them. Biogen – Where science meets humanity.